AVAX Technologies Inc (AVXT)

[lefty18]

Cha-Ching.

Dr. Coukos anticipates that in the future, immunotherapy in combination with surgery and chemotherapy will become a standard of care for ovarian cancer.

As it points out in the article, a big reason why the cancer vaccine has a higher than usual chance of approval by the FDA is:

no toxicity.

You can add the cancer vaccine to any cancer treatment regimen and you don't have to worry about the chemo killing the patient or making him/her too ill to stand it.